3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1
2
Phase 4
1
Phase 3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thymoma
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Large Cell
1
Carcinoma
1
Advanced Gastric Cancer
1
Adenocarcinoma Pancreas
1
Adenocarcinoma
1
Interventions
nedaplatin
1
Fluorouracil
1
Fibrin Tissue Adhesive
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
Acitretin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Squamous Cell
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT02151149
2018-09-24
ABOUND 70+
Celgene
Phase 4
Completed
143 enrolled
25 charts